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Abstract: Background: Hypoglycemia is associated with a higher risk
of death. This study analyzed various body mass index (BMI)
categories and mortalities of severe hypoglycemic patients with type
2 diabetes mellitus (DM) in a hospital emergency department.Methods: The
study included 566 adults with type 2 diabetes who were admitted to 1
medical center in Taiwan between 2008 and 2009 with a diagnosis of
severe hypoglycemia. Mortality data, demographics, clinical character-
istics and the Charlson’s Comorbidity Index were obtained from the
electronic medical records. Patients were stratiﬁed into 4 study groups
as determined by the National Institute of Health (NIH) and World Health
Organization classiﬁcation for BMI, and the demographics were com-
pared using the analysis of variance and x2 test. Kaplan-Meier’s analysis
and the Cox proportional-hazards regression model were used for mor-
tality, and adjusted hazard ratios were adjusted for each BMI category
among participants. Results: After controlling for other possible con-
founding variables, BMI,18.5 kg/m2 was independently associated with
low survival rates in the Cox regression analysis of the entire cohort of
type 2 DM patients who encountered a hypoglycemic event. Compared to
patients with normal BMI, the mortality risk was higher (adjusted hazard
ratios 5 4.9; 95% conﬁdence interval [CI] 5 2.4–9.9) in underweight
patients. Infection-related causes of death were observed in 101 cases
(69.2%) and were the leading cause of death. Conclusions: An indepen-
dent association was observed between BMI less than 18.5 kg/m2 and
mortality among type 2 DM patient with severe hypoglycemic episode.
Deaths were predominantly infection related.
Key Indexing Terms: Hypoglycemia; Body mass index; Mortality;
Emergency department; Diabetes mellitus. [Am J Med Sci 2015;349
(3):192–198.]
S evere hypoglycemia is an acute complication of diabetestherapy. Although less common in patients with type 2
diabetes, severe hypoglycemia is a threat for the diabetic patient
treated with glucose-lowering drugs. Population-based data
indicate that the overall event rate for severe hypoglycemia in
type 2 diabetes would be equivalent to 0.35 events per patient
per year.1 The precipitating cause of severe hypoglycemia is not
always easy to ﬁnd. However, overtreatment of diabetes was
passed for an important cause of severe hypoglycemic reac-
tions.2 Studies have demonstrated that intensive glycemic con-
trol lowers micro- and macrovascular event risks,3,4 yet
a number of large randomized controlled trials have failed to
demonstrate a clear reduction in mortality with intensiﬁcation
of treatment.5–7 In addition, 3 large randomized trials
(ACCORD, ADVANCE and VADT) showed that a favorable
glycemic control (HbA1c 6.4%–6.9%) is associated with an
increased incidence of hypoglycemia with type 2 diabetes.7–9
Furthermore, recent studies have linked hypoglycemia with
angina, myocardial infarction and acute cerebrovascular events,
which results in an increased risk of cardiovascular disease and
all-cause mortality.8,10,11 The association between hypoglyce-
mia and increased risk of mortality in an intensive care unit
and general ward settings has also been demonstrated.12,13
McCoy et al14 also indicated that self-reported severe hypogly-
cemia is associated with a 3.4-fold increase in the risk of death.
We were interested in the body weight and outcome of
severe hypoglycemic patients with type 2 diabetes. Each 5 kg/m2
increase in body mass index (BMI) is associated with a signif-
icant increase in mortality from diabetes in overweight and
obese patients.15 We evaluated the association between severe
hypoglycemia and mortality after discharge and focused on
various BMI and other independent risk factors to quantify
the risk of mortality in the cohort. In addition, we examined
the major causes of mortality among these patients.
METHODS
Setting
This study was conducted at Kaohsiung Chang Gung
Memorial Hospital (KCGMH) in Taiwan. The hospital is the
largest medical center in Southern Taiwan. Its central location
serves as a primary national referral center for specialized care
for over 3 million people.
Design
This was a cohort study for patients with severe hypogly-
cemic type 2 diabetes in an emergency department (ED). We
identiﬁed all patients who visited the ED of the hospital between
January 1, 2008, and December 31, 2009 with a primary
discharge diagnosis of hypoglycemia (ICD-9 codes 251.0–
251.2) and then evaluated them as then prospective follow-up.
Participants were recruited based on the following inclusion cri-
teria: (1) 18 years of age or older, (2) type 2 diabetes mellitus
(DM), (3) severe hypoglycemic episode (ie, loss of consciousness
or major alteration of mental status that required the assistance of
another person on ED arrival) and (4) the symptoms of severe
hypoglycemia and impairment of mental function completely
relieved after resolution of hypoglycemia. The exclusion criteria
were the following: (1) traumatic event, (2) pregnant women,
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(3) transferred to another acute care hospital and (4) no in-hospital
follow-up for at least 3 months. DM was diagnosed according to
the criteria of The American Diabetic Association and Expert
Committee (1997). If a patient visited more than once during the
study period, only the ﬁrst hospitalization was abstracted. Data
from each patient who visited the ED at KCGMH were entered
into the electronic medical record (EMR) computerized registry.
These data included information on demographics, weight, height,
laboratory test values and current diabetes therapy. Each ED visit
included the measurement and calculation of blood sugar levels,
vital signs, Glasgow Coma Scale (GCS), serum creatinine levels
and the Charlson’s Comorbidity Index (CCI). Because the heights
and weights of all patients were not routinely measured and re-
corded during their ED visits, they were obtained from the hospi-
talized medical records or during the preceding 1 month of the
index ED visiting in the EMRs for calculation of the BMI. If the
data were unavailable, each patient and/or primary caregiver was
questioned and answers were recorded as self-reported data. The
CCI, which is the most widely used comorbidity index, is a scoring
system that includes weight factors on the basis of disease severity
and is used for measurement of the comorbid conditions of pa-
tients. The CCI was previously validated for use in patients with
diabetes16 and ED-revisiting patients.17 We used capillary blood
glucose levels for analysis. The BMI values were used to indicate
body fat status and were calculated from height and weight data
using the kg/m2 equation. Glycosylated hemoglobin (HbA1c) lev-
els recorded over 3 months were obtained from charts. The pri-
mary outcome was all-cause mortality, and mortality data were
obtained from the EMRs. Participants were considered alive if
there was a clinical encounter and censored if they did not have
an encounter without a documented death in the EMR during the
follow-up period. The information on the causes of death was also
recorded. All patients were subsequently evaluated, and we fol-
lowed this cohort of 566 patients for an average of 29.1 months.
Definition of Hypoglycemia
A plasma glucose concentration below 70 mg/dL is the
most common threshold used to deﬁne hypoglycemia.18 Hypo-
glycemia can be considered symptomatic and documented.
Patients with hypoglycemia who are brought to the ED usually
have at least 1 typical symptom of hypoglycemia (eg, palpita-
tions, hunger, sweating, tremulousness and/or dizziness). The
cutoff blood glucose level of 70 mg/dL was selected to deﬁne
biochemical hypoglycemia. Severe hypoglycemia was deﬁned
as an event of loss of consciousness or other major alteration of
mental status caused by hypoglycemia that required the assis-
tance of another person to treat the condition.
Patients
This study was conducted at a tertiary hospital that
serves the port city of Southern Taiwan. Among the 742
patients identiﬁed using a primary discharge diagnosis of
hypoglycemia in the computerized registry between January
2008 and December 2009, 29 (3.9%) were younger than 18
years, 52 (7.0%) were not type 2 DM patients (including type 1
diabetes and nondiabetes), 18 (2.4%) were not severe hypogly-
cemia patients, 17 (2.3%) without complete remission of the
symptoms of severe hypoglycemia and impairment of mental
function after resolution of hypoglycemia, 6 (0.8%) were
patients with trauma and 6 (0.8%) were transferred to other
health care systems after their ED visits. Among the 614
recruited patients, 48 (7.8%) were unable to attend our hospital
for further evaluation over the 3-month period. A retrospective
analysis of all patient data was approved by the Institutional
Review Board of KCGMH.
Statistical Analyses
All statistical analyses were performed using Stata
software version 11.0 (STATA Corp., TX). Continuous varia-
bles were compared using analysis of variance and were
expressed as mean 6 SD. The x2 test was used for comparison
of categorical variables. Kaplan-Meier’s estimates were used to
evaluate survival over time, with differences evaluated using
the log-rank test for equality of survivor functions. Cox pro-
portional hazard models were used to assess confounders. Age,
sex, BMI and CCI were included in the multivariate Cox pro-
portional hazard model, and the independent effects were pro-
duced to estimate predictor variables on survival. The adjusted
hazard ratio (aHR) and 95% conﬁdence intervals (CIs) were
also obtained. Other potential confounders were added, such
as blood pressure, heart rate, body temperature, treatment
modalities, serum creatinine, white-cell count, initial blood glu-
cose and GCS. Age, sex and CCI were retained in the ﬁnal
model based on clinical interest or an appreciable change
(610%) in the HR associated with BMI. All P values were 2
tailed, and a P value of , 0.05 was considered statistically
signiﬁcant.
RESULTS
Data were obtained for 566 patients at the hospital. The
characteristics and demographics of these patients with severe
hypoglycemia from the indexed ED visits are shown in Table 1.
TABLE 1. Demographic characteristics of the participantsa
Value (mean 6 SD)
Total participants 566
Age, y 74.0 6 11.0
Gender, male, % 233 (41.2%)
BMI, kg/m2 23.8 6 4.0
Vital signs at ED
Body temperature, °C 36.2 6 0.6
Heart rate, bpm 86 6 17
Respiratory rate, per minute 19 6 5
Systolic blood pressure, mm Hg 158 6 33
Diastolic blood pressure, mm Hg 81 6 18
Glucose level in ED, mg/dL 38 6 15
GCS 10.7 6 4.0
HbA1c in recent 3 mo, % 6.9 6 1.6
Serum creatine at ED, mg/dL 2.8 6 3.1
History, %
Cerebral vascular disease 26.7
Coronary artery disease 18.2
Chronic renal insufﬁciency 36.1
Malignancy 11.5
CCI 6 6 3
Drugs for DM control, %
Insulin only 15.9
Oral hypoglycemic agents only 71.0
Combination 7.4
Other alternative treatment 5.7
Admission, % 32.2
a Data are presented as mean 6 SD or n (%).
BMI, body mass index; CCI, Charlson’s Comorbidity Index; ED,
emergency department; GCS, Glasgow Coma Scale; HbA1c, glycated
hemoglobin.
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Patient age ranged from 21 to 99 years (mean: 74.0 6 11.0
years). Approximately, half (41.2%) of all patients were men.
The mean BMI was 23.8 6 4.0 kg/m2, the initial blood glucose
value was 37.7 6 14.6 mg/dL, GCS was 10.7 6 4.0, HbA1c
was 5.4 6 3.1%, serum creatinine was 3.9 6 3.1 mg/dL and
CCI was 6.2 6 2.7. The treatment modalities included insulin
only (15.9%), oral hypoglycemic agents only (71.0%), combi-
nation of insulin and oral hypoglycemic agents (7.4%) and
other alternative treatment. Approximately one-third (32.2%)
of all participants were admitted after emergency treatment.
BMI classiﬁcations were obtained from the NIH19 and
WHO.20 The patients were classiﬁed into four groups: under-
weight (BMI ,18.5 kg/m2), normal weight (18.5–24.9 kg/m2),
overweight ($25.0–29.9 kg/m2) and obese ($30 kg/m2).
Table 2 shows the demographic data, serum creatinine, HbA1c,
GCS and CCI among 4 BMI groups at the beginning of the
study. The differences did not reach statistical signiﬁcance
among these factors, except for age (P 5 0.0175). Post hoc test
reveals that the signiﬁcant difference was between BMI ,18.5
and BMI 5 25–29.9. Table 3 and Figure 1 show assessments
for mortality and aHR for various BMI categories among pa-
tients with type 2 DM with severe hypoglycemia. The mean
time from the index date to the occurrence of the ﬁrst hypogly-
cemic episode was 29.1 months, and the median time was 33.4
months. A total of 146 (25.8%) deaths occurred after reporting
an episode of severe hypoglycemia. Patients with a BMI of less
than 18.5 kg/m2 had a higher mortality density than patients
with a BMI between 18.5 and 25 kg/m2 (24.8 versus 9.8 per
1000 people-months and aHR 5 4.9). Patients with a BMI
between 25 and 29.9 and more than 30 had a lower mortality
density than those in the reference group (5.2, 2.4 versus 9.8 per
1000 people-months); however, the difference did not reach
statistical signiﬁcance (aHR 5 1.2 and 0.16; 95% CI 5 0.6–
2.2 and 0.0–1.2). The difference in cumulative mortality inci-
dence in the cohort was 16.1% at the 12-month follow-up,
21.1% at the 24-month follow-up, 26.6% at the 36-month
follow-up and 28.9% at the 48-month follow-up. The highest
mortality incidence was noted at the ﬁrst 12-month follow-up,
and the incidence was 5%, 5.1% and 2.7% at the subsequent 12-
month follow-up. The cumulative mortality incidence differ-
ence between the underweight group and reference group was
14.7% (32.7% versus 18.0%) at the 12-month follow-up, 22.4%
(43.9% versus 21.5%) at the 24-month follow-up, 28.7%
(56.4% versus 27.1%) at the 36-month follow-up and 31.3%
(62.7% versus 31.4%) at the 48-month follow-up. By contrast,
mortality rates increased during the follow-up period in the
underweight group. Cox regression analysis was used to model
aHR for mortality for each BMI category. After controlling for
other possible confounding variables, BMI ,18.5 kg/m2 was
independently associated with low survival in Cox regression
analysis of the entire cohort of type 2 DM patients with a hypo-
glycemic event. Compared with patients with a reference BMI,
the mortality risk was higher (aHR 5 4.9; 95% CI 5 2.4–9.9)
in underweight patients. No statistical signiﬁcance was
achieved for mortality risk in overweight (aHR 5 1.2; 95%
CI 5 0.6–2.2) and obese patients (aHR 5 0.16; 95% CI 5
0.0–1.2). The adverse interaction indicates that a BMI of less
than 18.5 kg/m2 considerably modiﬁes the effect of a hypogly-
cemic event on survival. The Kaplan-Meier’s survival estimates
are shown in Figure 2. A statistically signiﬁcant difference
among 4 BMI categories (log-rank test, x2 5 41.23; P ,
0.0001) was observed during the follow-up period. Cause of
death was reviewed for 146 nonsurvivors, and infection was
found to be the leading cause of death in the patients with
severe hypoglycemia (101 cases, 69.2%). More than half (57
cases, 56.4%) of all infected deceased patients had respiratory
tract infections and approximately one-third of deceased pa-
tients (34 cases, 33.7%) had urinary tract infections. There were
33 patients (32.6%) presented as sepsis (Table 4).
DISCUSSION
Meticulous glycemic control is a major concern for
patients with diabetes in recent decades. Several epidemiolog-
ical studies have reported an increased risk of death and
cardiovascular disease with increased levels of HbA1c,21–23
and the importance of efﬁcient glycemic control for protection
against microvascular and cardivascular disease was established
for patients with type 1 diabetes. Although the role of glycemic
control on microvascular disease in patients with type 2 diabe-
tes was documented in the United Kingdom Prospective Dia-
betes Study24 and other recent studies,4,7 the role of glycemic
control for reducing mortality has not yet been established for
patients with type 2 diabetes.5–7 Although most clinicians agree
that effective glycemic control is a desirable intervention for
patients with diabetes, the association with increased incidences
of hypoglycemia demonstrated in ACCORD, ADVANCE and
VADT trails has limited the treatment. The frequency of severe
hypoglycemia was low initially; it was increasing in the latter
TABLE 2. BMI categories in the severe hypoglycemic type 2 DM follow-up cohorta
BMI (kg/m2)
P\18.5 18.5–24.9 25–29.9 ‡30
No. participants 50 (8.8%) 314 (55.5%) 163 (28.8%) 39 (6.9%)
Age, y 75.2 6 13.6 74.7 6 11.0 73.3 6 9.2 69.2 6 12.2 0.0175
Gender, male 22 (44.0%) 122 (38.9%) 71 (43,6%) 18 (46.2%) 0.649
Serum creatine, mg/dL 2.5 6 2.4 2.8 6 3.1 2.6 6 3.0 3.9 6 3.9 0.1047
HbA1c, % 6.8 6 1.4 6.9 6 1.6 7.0 6 1.4 7.2 6 2.2 0.7101
WBC, 103/mL 8.8 6 5.8 9.1 6 3.2 8.8 6 3.1 9.1 6 3.2 0.9133
GCS 10.9 6 4.1 10.4 6 3.9 11.0 6 4.0 11.1 6 4.3 0.2866
Glucose level in ED, mg/dL 34.1 6 15.7 37.3 6 14.5 39.3 6 14.7 39.0 6 13.7 0.1552
CCI 6.9 6 3.2 6.5 6 2.7 5.9 6 2.5 5.2 6 2.3 0.0569
a Data are presented as mean 6 SD or n (%).
BMI, body mass index; CCI, Charlson’s Comorbidity Index; ED, emergency department; GCS, Glasgow Coma Scale; HbA1c, glycated
hemoglobin; WBC, white blood cell.
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part of the study in the United Kingdom Prospective Diabetes
Study.24 Patients who were clinically diagnosed with severe
hypoglycemia had 2.3- and 3.3-fold excess mortality rates in
the standard treatment arms of ACCORD25 and ADVANCE,10
respectively. A recent observational and prospective study also
indicated that patients who self-reported severe hypoglycemia
had a 3.4-fold higher risk of death after 5 years compared with
those who reported mild or no hypoglycemic symptoms.14
Therefore, patients with diabetes who developed severe hypo-
glycemia had inferior outcomes and higher mortality rates than
patients with diabetes.
This study describes the clinical characteristics of
a cohort of 566 consecutive patients admitted to the ED, and
each patient was diagnosed with type 2 diabetes and sustained
at least 1 episode of severe hypoglycemia, deﬁned as plasma
glucose level less than 70 mg/dL and associated with an event
of loss of consciousness or other major alteration of mental
status that required the assistance of another person. Our
ﬁndings reveal that underweight was associated with a high
risk of mortality in our cohort. Patients with a BMI of less than
18.5 kg/m2 exhibited a higher risk (aHR 5 4.9) of mortality
(independent of age, sex and CCI) than patients with a standard
TABLE 3. Mortality density, CM and aHR associated with BMI (kg/m2) among type 2 DM patients with severe hypoglycemia
Factor No. of patients Follow-up (person-months) No. deaths Mortality densitya 12-mo CM % (95% CI)
Total 566 16,469.2 146 8.9 16.1 (13.3–19.5)
BMI
,18.5 50 1169.20 29 24.8 32.7 (21.4–47.8)
18.5–24.9 314 8855.9 87 9.8 18.0 (14.1–22.8)
25–29.9 163 5198.6 27 5.2 10.6 (6.7–16.5)
$30 39 1245.5 3 2.4 2.6 (0.4–16.8)
Factor 24-mo CM % (95% CI) 36-mo CM % (95% CI) 48-mo CM % (95% CI) aHRb (95% CI)
Total 21.1 (17.9–24.8) 26.2 (22.5–30.3) 28.9 (24.9–33.3)
BMI
,18.5 43.9 (31.1–59.2) 56.4 (42.5–71.2) 62.7 (48.1–72.3) 4.9 (2.4–9.9)
18.5–24.9 21.5 (17.2–26.7) 27.1 (23.0–33.6) 31.4 (25.9–37.7) 1.0 (reference)
25–29.9 16.2 (11.2–23.1) 17.8 (12.5–24.9) 17.8 (12.5–24.9) 1.2 (0.6–2.2)
$30 8.5 (2.8–24.1) 8.5 (2.8–24.1) 8.5 (2.8–24.1) 0.16 (0.0–1.2)
a Mortality density was displayed as per 1000 people-months.
b aHR was adjusted for age, sex and CCI.
aHR, adjusted hazard ratio; BMI, body mass index; CM, cumulative mortality.
FIGURE 1. Flow diagram summarizing sample
recruitment of the study.
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BMI in the Cox analysis model. This was a remarkable ﬁnding,
despite the established association between obesity and
increased mortality.26
For individuals with type 2 diabetes, studies have
demonstrated that moderate weight loss (5% of body weight)
is associated with decreased insulin resistance and improved
measures of glycemia.27 However, the higher mortality among
patients in the underweight group was unexpected, and the
higher risk cannot be accounted for other covariables. A lower
BMI may partially reﬂect the effects of coexisting conditions,
such as malnutrition, especially in the presence of severe hypo-
glycemia. Malnutrition is demonstrated to be associated with
increased morbidity and mortality in patients with acute and
chronic diseases,28 and it impairs recovery and convalescence
and prolongs hospital stays.29 There was no objective evidence
that malnutrition was found in these 50 patients; even so, the
observations made are very suggestive. We noted that the pa-
tients with the highest CCI were the lower BMI group and those
with the lowest CCI were the obese patients, but we may not be
powered to demonstrate the difference. This suggests that the
lower BMI patients with diabetes are fundamentally different
and have an underlying pathophysiology different from the
other BMI groups, and as the CCI suggests, have a higher pre-
diction for mortality, which may explain their poor outcome. In
addition, we observed that the obese group had a lower mor-
tality risk compared with the standard BMI group (aHR5 0.16;
95% CI 5 0.0–1.2); however, this difference did not reach
statistical signiﬁcance. It is possible that the study population
was underpowered, and the observational period was insufﬁ-
cient to detect differences. However, the prognoses for over-
weight and obese participants were better than those for
underweight participants. This phenomenon is referred to as
the “obesity paradox.” Although its mechanism is unknown,
the obesity paradox has been reported in several patient cate-
gories, such as heart failure, stroke, coronary heart disease,
chronic hemodialysis, renal failure, COPD, cancer and rheuma-
toid arthritis. Overweight and obese patients may have a supe-
rior prognosis because obesity correlates with a superior
nutritional status.30 The results highlight the negative effect of
malnutrition instead of the positive inﬂuence of obesity in pa-
tients with severe hypoglycemia; this indicates that a standard
BMI or being overweight are crucial determinants of risk reduc-
tion in type 2 DM patients with severe hypoglycemia.
Infections alone or in combination with other causes
accounted for more than 60% of deaths in this study. Limited
information is available on the cause of death in patients with
severe hypoglycemia. Previous studies have indicated that
infection is one of the main causes of mortality in patients
with hypoglycemia. The NICE-SUGAR study indicated that
patients with severe hypoglycemia had a signiﬁcantly higher
HR for death from distributive shock compared with patients
without hypoglycemia (aHR 5 4.35; 95% CI 5 2.49–7.61).31
Egi et al32 indicated that hypoglycemia was independently asso-
ciated with the death caused by infectious disease (51.6%, 128
of 248 cases). The prevalence of infection may have been
FIGURE 2. Kaplan-Meier’s survival estimates by each BMI cate-
gories of severe hypoglycemia with type 2 DM patient. BMI,
body mass index; DM, diabetes mellitus.
TABLE 4. Causes of death in 146 diabetic patients with
severe hypoglycemiaa,b
Total
causes
Contributory
causes
Single
cause
Infections 101 (69.2) 81 (55.5) 20 (32.2)
Respiratory tract 57 (39.0) 48 (32.9) 9 (6.2)
Genitourinary tract 34 (23.3) 29 (19.9) 5 (3.4)
Gastrointestinal tract 6 (4.1) 5 (3.4) 1 (0.7)
Soft tissue 14 (9.6) 13 (8.9) 1 (0.7)
Biliary tract 4 (2.7) 3 (2.1) 1 (0.7)
Central nervous system 0 (0) 0 (0) 0 (0)
Other 20 (13.7) 16 (11.0) 4 (2.7)
Sepsis 33 (32.6) 33 (32.6) 0 (0)
Malignancy 40 (27.4) 31 (21.2) 9 (6.2)
Liver 13 (8.9) 8 (5.5) 5 (3.4)
Lung 10 (6.8) 9 (6.2) 1 (0.7)
Colorectum 4 (2.7) 3 (2.1) 1 (0.7)
Pancreas 4 (2.7) 3 (2.1) 1 (0.7)
Prostate 2 (1.4) 0 (0) 2 (1.4)
Breast 3 (2.1) 2 (1.4) 1 (0.7)
Kidney 1 (0.7) 1 (0.7) 0 (0)
Stomach 1 (0.7) 1 (0.7) 0 (0)
Esophagus 2 (1.4) 2 (1.4) 0 (0)
Other 5 (3.4) 5 (3.4) 0 (0)
Cardiogenic causes 37 (25.3) 28 (19.2) 9 (6.2)
Hear failure 20 (13.7) 18 (12.3) 2 (1.4)
Coronary artery disease 16 (11) 10 (6.8) 6 (4.1)
Arrhythmia 9 (6.2) 6 (4.1) 3 (2.1)
Cardiomyopathy 1 (0.7) 1 (0.7) 0 (0)
Gastrointestinal bleeding 24 (16.4) 22 (15.1) 2 (1.4)
Acute renal failure 20 (13.7) 20 (13.7) 0 (0)
Chronic liver disease 19 (13) 13 (8.9) 6 (4.1)
Stroke 12 (8.2) 12 (8.2) 0 (0)
Chronic obstruction
pulmonary disease
7 (4.8) 2 (1.4) 5 (1.4)
Acute respiratory distress
syndrome
3 (2.1) 1 (0.7) 2 (1.4)
Pulmonary
thromboembolism
1 (0.7) 1 (0.7) 0 (0)
Acute pancreatitis 1 (0.7) 1 (0.7) 0 (0)
Miscellaneous 17 (11.6) 3 (2.1) 14 (9.6)
Multiple causes 99 (67.8) — —
a Values in parentheses are percentages.
b Single cause refers to the mention of the only cause of death on the
death certiﬁcate, whereas contributory cause refers any other causes
mentioned on the death certiﬁcate.
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higher in this study. The unfavorable causal relationship is
plausible because hypoglycemia may increase mortality by
impairment of autonomic function, alteration of blood ﬂow
and composition, vasoconstriction, white-cell activation and
the release of inﬂammatory mediators and cytokines.33,34
The all-cause mortality rate of adults with severe
hypoglycemia was 25.8% at 4 years in this study, which was
higher than the 23.7% in the self-reported severe hypoglycemia
study at 5 years14 and the 19.5% in the ADVANCE study at 5
years.10 A signiﬁcant correlation between severe hypoglycemia
and increased mortality was consistently demonstrated. The
discrepancies and high mortality rate of patients with severe
hypoglycemia may be partially attributed to the small sample
size and the problems that are inherent to ED population-based
studies, such as an older population, higher patient comorbidity,
more severe and critical diseases, higher patient ﬂow, delayed
or missed diagnoses and overcrowding. These factors may pres-
ent a therapeutic challenge for physicians when treating a spe-
ciﬁc group of patients. Regardless of the fact that high mortality
was observed, it was striking that only one-third of these pa-
tients were admitted after emergency treatment.
Limitations
The main strengths of this study include its complete
recruitment, comprehensive data collection and follow-up.
However, this study had certain limitations. First, the main
limitation was the small sample size, and the results must be
conﬁrmed in larger registries in the future. Second, this study
was a single-center examination of patients in the ED, although
the assessment of an accurate weight and height in critical
patients may be difﬁcult. Because the heights and weights of all
patients were not routinely measured and recorded during their
ED visits, we had to rely on self-report if these data were not
available. We relied on only 1 weight and height measurement
from the ED, which is a major limitation of this study. Forty-
ﬁve participants (7.9%) were recorded by self-report among all
precipitants. To assess bias, we compared the participants
whose BMI were hospital recorded and self-reported. However,
self-reported BMI did not differ importantly from the rest of the
cohort with respect to baseline characteristics (Table 5) (all
P values , 0.05) and would not potentially bias outcome data
in a more favorable direction.
Finally, we were unable to obtain information on the
frequency of severe hypoglycemic episodes and whether the
index visit was the ﬁrst hypoglycemia event. The fortuitous
severe hypoglycemia could not be differentiated as to whether it
was the ﬁrst-ever or recurrent hypoglycemic episode for each
patient. The differences of clinical characteristics, pathophysi-
ology, mechanisms and medical care between the ﬁrst hypo-
glycemia event and recurrent hypoglycemia events were not
effectively examined. Merging these patients may cause non-
differential misclassiﬁcation and bias the results.
CONCLUSIONS
To the best of our knowledge, this is the ﬁrst study on
severe hypoglycemia in an ED. The results of this study showed
that the crucial prognostic factor with statistical signiﬁcance for
increased risk of death was BMI less than 18.5 kg/m2 among
adult patients with type 2 diabetes with severe hypoglycemia.
Excessive low weight may identify patients with particularly
high mortality risks and may be a marker or trigger to
TABLE 5. Baseline characteristics of the 2 groups of hospital-recorded BMI and self-reported BMIa
Patients with hospital-recorded
BMI (n 5 521)
Patients with self-reported
BMI (n 5 45) P
Age, y 74.2 6 0.5 71.7 6 1.9 0.1969
Gender, male (%) 215 (41.3%) 18 (40%) 0.868
BMI (kg/m2) 23.8 6 4.2 23.7 6 0.2 0.5628
Vital signs at ED
Body temperature, °C 36.2 6 0.6 36.1 6 0.6 0.6240
Heart rate, bpm 86 6 16 84 6 17 0.5250
Respiratory rate, per minute 19.4 6 0.2 19.7 6 0.4 0.4665
Mean arterial pressure, mm Hg 107 6 20 100 6 22 0.0529
Glucose level in ED, mg/dL 37.7 6 14.4 37.9 6 16.5 0.9191
GCS 10.6 6 4.0 10.4 6 3.7 0.6386
HbA1c in recent 3 mo, % 6.9 6 1.5 7.2 6 2.0 0.3375
WBC, 103/mL 8.9 6 3.5 9.7 6 4.2 0.3655
Serum creatine at ED, mg/dL 2.7 6 0.3.0 3.1 6 3.4 0.4232
CCI 6.2 6 2.7 6.6 6 3.0 0.5759
Drugs for DM control, % 0.854
Insulin only 82 (15.7) 8 (17.8)
Oral hypoglycemic agents only 370 (71.0) 32 (71.1)
Combination 40 (7.7) 2 (4.4)
Other alternative treatment 29 (5.57) 3 (6.7)
Admission, % 166 (31.9) 16 (35.6) 0.2591
ED length of stay 21.2 6 34.4 19.5 6 39.0 0.7821
Hospital length of stay 5.2 6 117.4 7.3 6 19.0 0.5871
a Data are presented as mean 6 SD or n (%).
BMI, body mass index; CCI, Charlson’s Comorbidity Index; DM, diabetes mellitus; ED, emergency department; GCS, Glasgow Coma Scale;
HbA1c, glycated hemoglobin; WBC, white blood cell.
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exacerbate underlying diseases. The results reveal an associa-
tion between type 2 diabetes with a low BMI and increased
short- and long-term mortality and highlight the requirement
for a new therapeutic approach for severe hypoglycemia in
patients with type 2 diabetes, especially for underweight group.
According to the result of the study, admission after emergency
treatment for advanced surveying possible concomitant diseases
such as infection is recommended. Physician, dieticians and
nurses must collaborate to develop an interdisciplinary assess-
ment of these patients to maintain an optimal nutritional status
and beware of underweight if severe hypoglycemia was identi-
ﬁed. In conclusion, an independent association was observed
between a BMI of less than 18.5 kg/m2 and mortality among
type 2 DM patients with severe hypoglycemic episode when
compared to those with normal or high BMIs. Deaths for all
patients were predominantly infection related.
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